Traws Pharma, Inc.TRAWNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank29
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-25.44M
↑ 29% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-35.90M
Historical baseline
PeriodValueYoY Change
TTM$-25.44M+84.7%
2024$-166.51M-721.0%
2023$-20.28M-3.4%
2022$-19.61M-19.0%
2021$-16.48M+34.0%
2020$-24.98M-15.2%
2019$-21.68M-5.9%
2018$-20.48M+14.6%
2017$-23.99M-22.7%
2016$-19.56M-